138 related articles for article (PubMed ID: 34655135)
1. Safety and efficacy of a mucoadhesive phytomedication containing curcuminoids and Bidens pilosa L. extract in the prevention and treatment of radiochemotherapy-induced oral mucositis: Triple-blind, randomized, placebo-controlled, clinical trial.
Arantes DAC; da Silva ACG; Freitas NMA; Lima EM; de Oliveira AC; Marreto RN; Mendonça EF; Valadares MC
Head Neck; 2021 Dec; 43(12):3922-3934. PubMed ID: 34655135
[TBL] [Abstract][Full Text] [Related]
2. Randomized clinical trial of a mucoadhesive formulation containing curcuminoids (Zingiberaceae) and Bidens pilosa Linn (Asteraceae) extract (FITOPROT) for prevention and treatment of oral mucositis - phase I study.
Santos Filho EXD; Arantes DAC; Oton Leite AF; Batista AC; Mendonça EF; Marreto RN; Naves LN; Lima EM; Valadares MC
Chem Biol Interact; 2018 Aug; 291():228-236. PubMed ID: 29906455
[TBL] [Abstract][Full Text] [Related]
3. Effects of a mucoadhesive phytomedicine (Curcuma longa L. and Bidens pilosa L.) on radiotherapy-induced oral mucositis and quality of life of patients undergoing head and neck cancer treatment: randomized clinical trial.
Martins AFL; Pereira CH; Morais MO; de Sousa-Neto SS; Valadares MC; Freitas NMA; Leles CR; de Mendonça EF
Support Care Cancer; 2023 Aug; 31(9):517. PubMed ID: 37566179
[TBL] [Abstract][Full Text] [Related]
4. Biological effects of formulation containing curcuminoids and Bidens Pilosa L. in oral carcinoma cell line.
Arantes DAC; Silva ACGD; Lima EM; Alonso ECP; Marreto RN; Mendonça EF; Valadares MC; Batista AC
Braz Oral Res; 2021; 35():e063. PubMed ID: 34076188
[TBL] [Abstract][Full Text] [Related]
5. Effect of photobiomodulation on the severity of oral mucositis and molecular changes in head and neck cancer patients undergoing radiotherapy: a study protocol for a cost-effectiveness randomized clinical trial.
Martins AFL; Nogueira TE; Morais MO; Oton-Leite AF; Valadares MC; Batista AC; Freitas NMA; Leles CR; Mendonça EF
Trials; 2019 Feb; 20(1):97. PubMed ID: 30709370
[TBL] [Abstract][Full Text] [Related]
6. The effectiveness of Zataria extract mouthwash for the management of radiation-induced oral mucositis in patients: a randomized placebo-controlled double-blind study.
Aghamohammadi A; Moslemi D; Akbari J; Ghasemi A; Azadbakht M; Asgharpour A; Hosseinimehr SJ
Clin Oral Investig; 2018 Jul; 22(6):2263-2272. PubMed ID: 29313134
[TBL] [Abstract][Full Text] [Related]
7. A multinational, randomized phase III trial of iseganan HCl oral solution for reducing the severity of oral mucositis in patients receiving radiotherapy for head-and-neck malignancy.
Trotti A; Garden A; Warde P; Symonds P; Langer C; Redman R; Pajak TF; Fleming TR; Henke M; Bourhis J; Rosenthal DI; Junor E; Cmelak A; Sheehan F; Pulliam J; Devitt-Risse P; Fuchs H; Chambers M; O'Sullivan B; Ang KK
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):674-81. PubMed ID: 14967419
[TBL] [Abstract][Full Text] [Related]
8. Chemopreventive effects of FITOPROT against 5-fluorouracil-induced toxicity in HaCaT cells.
Dos Santos Filho EX; da Silva ACG; de Ávila RI; Batista AC; Marreto RN; Lima EM; de Oliveira CMA; Mendonça EF; Valadares MC
Life Sci; 2018 Jan; 193():300-308. PubMed ID: 28962868
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of Dentoxol® in the prevention of radiation-induced oral mucositis in head and neck cancer patients (ESDOM): a randomized, multicenter, double-blind, placebo-controlled, phase II trial.
Lalla RV; Solé S; Becerra S; Carvajal C; Bettoli P; Letelier H; Santini A; Vargas L; Cifuentes A; Larsen F; Jara N; Oyarzún J; Feinn R; Bustamante E; Martínez B; Rosenberg D; Galván T
Support Care Cancer; 2020 Dec; 28(12):5871-5879. PubMed ID: 32266567
[TBL] [Abstract][Full Text] [Related]
10. Effect of low-level laser therapy on chemoradiotherapy-induced oral mucositis and salivary inflammatory mediators in head and neck cancer patients.
Oton-Leite AF; Silva GB; Morais MO; Silva TA; Leles CR; Valadares MC; Pinezi JC; Batista AC; Mendonça EF
Lasers Surg Med; 2015 Apr; 47(4):296-305. PubMed ID: 25824475
[TBL] [Abstract][Full Text] [Related]
11. Randomized double-blind placebo-controlled trial of celecoxib for oral mucositis in patients receiving radiation therapy for head and neck cancer.
Lalla RV; Choquette LE; Curley KF; Dowsett RJ; Feinn RS; Hegde UP; Pilbeam CC; Salner AL; Sonis ST; Peterson DE
Oral Oncol; 2014 Nov; 50(11):1098-103. PubMed ID: 25151488
[TBL] [Abstract][Full Text] [Related]
12. Randomized Phase 2 Trial of a Novel Clonidine Mucoadhesive Buccal Tablet for the Amelioration of Oral Mucositis in Patients Treated With Concomitant Chemoradiation Therapy for Head and Neck Cancer.
Giralt J; Tao Y; Kortmann RD; Zasadny X; Contreras-Martinez J; Ceruse P; Arias de la Vega F; Lalla RV; Ozsahin EM; Pajkos G; Mazar A; Attali P; Bossi P; Vasseur B; Sonis S; Henke M; Bensadoun RJ
Int J Radiat Oncol Biol Phys; 2020 Feb; 106(2):320-328. PubMed ID: 31669562
[TBL] [Abstract][Full Text] [Related]
13. The Effect of Photobiomodulation on Nitrite and Inflammatory Activity in Radiotherapy-Induced Oral Mucositis: A Randomized Clinical Trial.
Martins AFL; Morais MO; Sousa-Neto SS; Oton-Leite AF; Pereira CH; Valadares MC; Freitas NMA; Batista AC; Leles CR; Mendonça EF
Lasers Surg Med; 2021 Jul; 53(5):671-683. PubMed ID: 32997817
[TBL] [Abstract][Full Text] [Related]
14. Phenylbutyrate mouthwash mitigates oral mucositis during radiotherapy or chemoradiotherapy in patients with head-and-neck cancer.
Yen SH; Wang LW; Lin YH; Jen YM; Chung YL
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1463-70. PubMed ID: 21840136
[TBL] [Abstract][Full Text] [Related]
15. Extraoral photobiomodulation for prevention of oral and oropharyngeal mucositis in head and neck cancer patients: interim analysis of a randomized, double-blind, clinical trial.
Kauark-Fontes E; Migliorati CA; Epstein JB; Treister NS; Alves CGB; Faria KM; Palmier NR; Rodrigues-Oliveira L; de Pauli Paglioni M; Gueiros LAM; da Conceição Vasconcelos KGM; de Castro G; Leme AFP; Lopes MA; Prado-Ribeiro AC; Brandão TB; Santos-Silva AR
Support Care Cancer; 2022 Mar; 30(3):2225-2236. PubMed ID: 34708311
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of curcumin for amelioration of radiotherapy-induced oral mucositis: a preliminary randomized controlled clinical trial.
Ramezani V; Ghadirian S; Shabani M; Boroumand MA; Daneshvar R; Saghafi F
BMC Cancer; 2023 Apr; 23(1):354. PubMed ID: 37069504
[TBL] [Abstract][Full Text] [Related]
17. Oral mucositis prevention by low-level laser therapy in head-and-neck cancer patients undergoing concurrent chemoradiotherapy: a phase III randomized study.
Gouvêa de Lima A; Villar RC; de Castro G; Antequera R; Gil E; Rosalmeida MC; Federico MH; Snitcovsky IM
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):270-5. PubMed ID: 21163585
[TBL] [Abstract][Full Text] [Related]
18. Palifermin reduces severe mucositis in definitive chemoradiotherapy of locally advanced head and neck cancer: a randomized, placebo-controlled study.
Le QT; Kim HE; Schneider CJ; Muraközy G; Skladowski K; Reinisch S; Chen Y; Hickey M; Mo M; Chen MG; Berger D; Lizambri R; Henke M
J Clin Oncol; 2011 Jul; 29(20):2808-14. PubMed ID: 21670453
[TBL] [Abstract][Full Text] [Related]
19. A randomized, double-blind, placebo-controlled trial of probiotics to reduce the severity of oral mucositis induced by chemoradiotherapy for patients with nasopharyngeal carcinoma.
Jiang C; Wang H; Xia C; Dong Q; Chen E; Qiu Y; Su Y; Xie H; Zeng L; Kuang J; Ao F; Gong X; Li J; Chen T
Cancer; 2019 Apr; 125(7):1081-1090. PubMed ID: 30521105
[TBL] [Abstract][Full Text] [Related]
20. Effect of low-level laser therapy on patient reported measures of oral mucositis and quality of life in head and neck cancer patients receiving chemoradiotherapy--a randomized controlled trial.
Gautam AP; Fernandes DJ; Vidyasagar MS; Maiya AG; Nigudgi S
Support Care Cancer; 2013 May; 21(5):1421-8. PubMed ID: 23224689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]